EZH2 Promotes Malignant Phenotypes in Patients with Oral Premalignancy

来源 :第十二次全国医学遗传学学术会议 | 被引量 : 0次 | 上传用户:hdc988
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Oral leukoplakia (OL) is the most common premalignant lesion in the site of oral cavity.However, only a small proportion of OLs progress to oral squamous cell carcinoma (OSCC).For early identification of high risk OLs, we investigated the role of the transcriptional repressor, enhancer of Zeste homolog 2 (EZH2), in oral carcinogenesis and the clinical implication of EZH2 as a biornarker for malignant transformation.Materials and Methods Leuk-1 cells were treated with anti-EZH2 siRNA to reduce EZH2 expression and measured for cell cycle distribution, anchorage dependent /independent growth and invasion.Immunohistochemistry was used to measure EZH2 protein levels in OLs of 81 patients.EZH2 protein levels were associated with pathological parameters and clinical outcomes.Results EZH2 inhibition in Leuk-1 cells decreased Leuk-1s invasion capability (P<.01) and anchorage dependent/ independent growth (P<.01),down-regulated cyclin-D1, up-regulated p15INK4B, and increased G1 phase.High expression of EZH2 in OLs was strongly associated with dysplastic histology (P<.0001) and OSCC development (P<.0001by Log-rank test).In the multivariate analysis, EZH2 level is the independent factor for OSCC development (P<.0001).At three years after the tissue examination, none of the 16 patients with EZH2 negative OL developed OSCC whereas 3(11.5%) of the 26 patients with moderate EZH2 expression and 30(76.92%) of the 39 patients with high EZH2 expression developed OSCC (P<.0001).Conclusion The results support the role of EZH2 in oral cancer malignant transformation and suggest that EZH2 may serve as a biomarker to predict OSCC risk and potential target in OSCC prevention.
其他文献
Objective In prenatal diagnostics, both microarray comparative genomic hybridization (array CGH) and single nucleotide polymorphism (SNP) genotyping have proven to be powerful genomic technologies uti
Purpose Neuronal loss and axonal degeneration are important pathological features of many neurodegenerative diseases.The molecular mechanisms underlying the majority of axonal degeneration conditions
目的 探讨高分辨熔解曲线(HRM)方法检测SCN1A基因突变所致Dravet综合征的可行性.方法 应用HRM的方法检测中国人群中常见的4种由SCN1A基因点突变所致的Dravet综合征(3个SCN1A:c.4283+2T>C,2个SCN1A:c.1216G>T,1个SCN1A:c.4243T>A,1个SCN1A:c.5768A>G)进行检测,同时加入正常野生型样本11例进行检测.结果 HRM的方法
研究背景 Crigler-Najjar-Ⅰ综合征(CNS)是一种伴有核黄疸的新生儿非溶血性家族性黄疸,为先天性间接胆红素血症的最严重的一种.CNS-Ⅰ型是一种罕见的常染色体隐性遗传病.该病致病基因是UGT1A1,位于2q37.CNS-Ⅰ由于肝细胞内微粒体重葡萄糖醛酰转移酶的缺乏,影响胆红素的结合,患者在出生后迅速出现显著、持续的黄疸,血清间接胆红素为300~850umol/L,通常大于340umo
目的 头颈癌的个体化诊断和治疗需要分子分类方法的支持.本研究的主要目的是建立头颈鳞癌分子分类技术和方法,并对潜在的生物标志物进行筛选、分析和验证,以确定头颈鳞癌分子诊断、分化程度、侵袭和转移等相关的分子靶点.材料与方法 在前期基因表达谱研究初步筛选的78个头颈鳞癌相关基因基础上,采用Real-time PCR的方法在mRNA水平检测了120例口腔颌面-头颈临床肿瘤组织标本和120例正常组织标本中7
Objective Dysregulated microRNAs (miRNAs) play an important role in many malignant tumors.However, elucidating the roles of miRNAs in cancer biology, especially m head and neck epithelial cancers, rem
非可控性炎症启动并参与了癌症的发生、发展、浸润转移和抵抗治疗等各个病理过程。研究表明癌变过程中调控的关键节点多和应激、炎症、免疫相关,炎症相关信号通路、尤其是NF-κB通路在慢性炎症癌变和转移中发挥关键调控作用;在口腔黏膜癌变过程中,上游miRNA基因调控网络发挥了十分关键的作用。报告重点介绍,以口腔癌前病变和口腔黏膜癌变模型为研究对象,针对癌启动、促进和发展过程,确立恶性转化时空节点的miRNA
Advances have been made in the past few decades in diagnosing cancers including improved imaging systems, endoscopies, and blood tests.However, significant portion of patients with cancer diagnosed at
Over the past decades, thermoablative techniques for the therapy of localized tumors have gained importance in the treatment of patients not eligible for surgical resection.Anecdotal reports have desc
会议
HSF4 mutations lead to both congenital and age-related cataract.The purpose of this study was to explore the mechanism of cataract formation caused by HSF4 mutations.The degradation of nuclear DNA is